XML 17 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Operating Activities:        
Net earnings $ 120,606 $ 107,949 $ 322,928 $ 321,435
Adjustments to reconcile net earnings to net cash from operating activities:        
Provision for losses on accounts receivable 1,741 1,321 3,187 2,461
Deferred income tax (benefit) expense (28,854) (1,439) (16,000) 2,342
Stock compensation expense 11,210 10,476 39,036 34,264
Depreciation and amortization 12,272 11,882 36,241 34,853
Other, net 377 11 (148) 41
Changes in operating assets and liabilities:        
(Increase) decrease in accounts receivable (126,102) (58,279) (123,790) 6,087
Increase in accounts payable and accrued expenses 61,833 38,070 96,132 74,148
Increase (decrease) in income taxes payable, net 38,149 7,197 10,814 (16,612)
Increase in other current assets (5,872) (1,395) (6,147) (2,089)
Net cash from operating activities 85,360 115,793 362,253 456,930
Investing Activities:        
Purchase of property and equipment (34,462) (12,659) (67,603) (39,973)
Other, net (261) 1,617 (892) 5,472
Net cash from investing activities (34,723) (11,042) (68,495) (34,501)
Financing Activities:        
Proceeds from issuance of common stock 65,915 57,522 162,781 147,645
Repurchases of common stock (202,776) (101,690) (340,736) (268,097)
Dividends paid 0 0 (75,726) (73,000)
Net cash from financing activities (136,861) (44,168) (253,681) (193,452)
Effect of exchange rate changes on cash and cash equivalents 4,758 1,853 18,932 5,927
(Decrease) increase in cash and cash equivalents (81,466) 62,436 59,009 234,904
Cash and cash equivalents at beginning of period 1,114,910 980,264 974,435 807,796
Cash and cash equivalents at end of period 1,033,444 1,042,700 1,033,444 1,042,700
Taxes Paid:        
Income taxes $ 58,257 $ 58,696 $ 190,911 $ 205,049